Formation of plexiform lesions in experimental severe pulmonary arterial hypertension

Circulation

Volumn 121, Issue 25, 2010, Pages 2747-2754

  Abe, Kohtaro ^a,b   Toba, Michie ^b   Alzoubi, Abdallah ^b   Ito, Masako ^b   Fagan, Karen A ^b   Cool, Carlyne D ^c   Voelkel, Norbert F ^d   McMurtry, Ivan F ^a,b   Oka, Masahiko ^a,b  

^a UNIVERSITY OF SOUTH ALABAMA   (United States)

^b UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

hypertension, pulmonary; pathology; remodeling; SU5416

Indexed keywords

SEMAXANIB;

ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERY INTIMA PROLIFERATION; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; DISEASE SEVERITY; HEART RIGHT VENTRICLE HYPERTROPHY; HEART RIGHT VENTRICLE PRESSURE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HUMAN VERSUS ANIMAL COMPARISON; HYPOXIA; IMMUNOHISTOCHEMISTRY; LUNG HEMODYNAMICS; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY PLEXIFORM LESION; PULMONARY HYPERTENSION; PULMONARY VASCULAR DISEASE; RAT; SYSTOLIC BLOOD PRESSURE; TIME;

ANIMALS; ANOXIA; ARTERIES; DISEASE MODELS, ANIMAL; HYPERTENSION, PULMONARY; LUNG; RATS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954243018     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.927681     Document Type: Article

References (25)

1. Humbert M, Sitbon O, Simonneau G. Treatment of pulmonary arterial hypertension. N Engl J Med. 2004;351:1425-1436.
2. Reeves JT, Groves BM, Turkevich D. The case for treatment of selected patients with primary pulmonary hypertension. Am Rev Respir Dis. 1986; 134:342-346.
3. Tuder RM. Pathology of pulmonary arterial hypertension. Semin Respir Crit Care Med. 2009;30:376-385.
4. Mooi WJ, Grünberg K. Histopathology of pulmonary hypertensive diseases. Curr Diagn Pathol. 2006;12:429-440.
5. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, Tuder RM. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol. 2004;43:25S-32S.
6. Meyrick B. The pathology of pulmonary artery hypertension. Clin Chest Med. 2001;22:393-404.
7. Wagenvoort CA. Plexogenic arteriopathy. Thorax. 1994;49:S39-S45.
8. Fishman AP. Changing concepts of the pulmonary plexiform lesion. Physiol Res. 2000;49:485-492.
9. Voelkel NF, Tuder RM. Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest. 2000;106:733-738.
10. Bauer NR, Moore TM, McMurtry IF. Rodent models of PAH: are we there yet? Am J Physiol Lung Cell Mol Physiol. 2007;293:L580-L582.
11. Stenmark KR, Meyrick B, Galie N, Mooi WJ, McMurtry IF. Animal models of pulmonary arterial hypertension: the hope for etiologic discovery and pharmacologic cure. Am J Physiol Lung Cell Mol Physiol. 2009;297:L1013-L1032.
12. Herget J, Suggett AJ, Leach E, Barer GR. Resolution of pulmonary hypertension and other features induced by chronic hypoxia in rats during complete and intermittent normoxia. Thorax. 1978;33:468-473.
13. Taraseviciene-Stewart L, Kasahara Y, Alger L, Hirth P, Mc Mahon G, Waltenberger J, Voelkel NF, Tuder RM. Inhibition of the VEGF receptor 2 combined with chronic hypoxia causes cell death-dependent pulmonary en-dothelial cell proliferation and severe pulmonary hypertension. FASEB J. 2001;15:427-438.
14. Oka M, Homma N, Taraseviciene-Stewart L, Morris KG, Kraskauskas D, Burns N, Voelkel NF, McMurtry IF. Rho kinase-mediated vasocon-striction is important in severe occlusive pulmonary arterial hypertension in rats. Circ Res. 2007;100:923-929.
15. Heath D, Smith P, Gosney J, Mulcahy D, Fox K, Yacoub M, Harris P. The pathology of the early and late stages of primary pulmonary hypertension. Br Heart J. 1987;58:204-213.
16. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA. Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc. 2008;3:1422-1434.
17. Homma N, Nagaoka T, Karoor V, Imamura M, Taraseviciene-Stewart L, Walker LA, Fagan KA, McMurtry IF, Oka M. Involvement of RhoA/Rho kinase signaling in protection against monocrotaline-induced pulmonary hypertension in pneumonectomized rats by dehydroepiandrosterone. Am J Physiol Lung Cell Mol Physiol. 2008;295:L71-L78.
18. Cool CD, Stewart JS, Werahera P, Miller GJ, Williams RL, Voelkel NF, Tuder RM. Three-dimensional reconstruction of pulmonary arteries in plexiform pulmonary hypertension using cell-specific markers: evidence for a dynamic and heterogeneous process of pulmonary endothelial cell growth. Am J Pathol. 1999;155:411-419.
19. Tuder RM, Marecki JC, Richter A, Fijalkowska I, Flores S. Pathology of pulmonary hypertension. Clin Chest Med. 2007;28:23-42.
20. Heath D, Edwards JE. The pathology of hypertensive pulmonary vascular disease; a description of six grades of structural changes in the pulmonary arteries with special reference to congenital cardiac septal defects. Circulation. 1958;18:533-547.
21. Hirose S, Hosoda Y, Furuya S, Otsuki T, Ikeda E. Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension. Pathol Int. 2000;50:472-479.
22. Greenway S, van Suylen RJ, Du Marchie Sarvaas G, Kwan E, Ambart-sumian N, Lukanidin E, Rabinovitch M. S100A4/Mts1 produces murine pulmonary artery changes resembling plexogenic arteriopathy and is increased in human plexogenic arteriopathy. Am J Pathol. 2004;164: 253-262.
23. White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, Miller CM, Blaxall BC, Hall CM, Pierce RA, Cool CD, Taubman MB. Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007;293:L583-L590.
24. Wagenvoort CA, Wangenvoort N. Primary pulmonary hypertension: a pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation. 1970;18:1163-1184.
25. Johnson SR, Granton JT, Mehta S. Thrombotic arteriopathy and antico-agulation in pulmonary hypertension. Chest. 2006;130:545-552.